Garnett Timothy John
SEC CIK 1998937 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | Dir | 53.5K | $252.7K | — | 3 | 2025-10-27 | 2026-06-23 |
Most active insiders at MPLT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Catalyst4, Inc. | 10% | $157.89M | — |
| 2 | Novo Holdings A/S | 10% | $16.20M | — |
| 3 | Kroeger Christopher A. | CEO, Dir | — | $12.54M |
| 4 | GILLIS JONATHAN | CAO, Interim CFO | — | $3.56M |
| 5 | Foff Erin Pennock | Chief Medical Off | — | $3.38M |
| 6 | Kreitzer Anatol | Chief Discovery Off | — | $2.78M |
| 7 | Lillie James Woodruff | CSO | — | $2.56M |
| 8 | Hanson Kristopher | GC | — | $1.66M |
| 9 | Malenka Robert C. | Dir | — | $1.60M |
| 10 | Setia Vishwas | CFO | — | $1.10M |
| 12 | Garnett Timothy John | Dir | $252.7K | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-25 17:59 | 2026-06-23 | MPLT | MapLight Therapeutics, Inc. | Garnett Timothy John | Dir | A - Grant | $0.00 | +3,932 | 53.5K | +8% | $0 |
| I | 2026-02-12 | 2026-02-10 | MPLT | MapLight Therapeutics, Inc. | Garnett Timothy John | Dir | P - Purchase | $17.89 | +14.1K | 14.1K | New | +$252.7K |
| D | 2025-10-28 | 2025-10-27 | MPLT | MapLight Therapeutics, Inc. | Garnett Timothy John | Dir | A - Grant | $0.00 | +6,294 | 6,294 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations